Sexual Health clinical trials

Explore recruiting sexual health clinical trials.

Recruiting sexual health studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Sexual Health trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A multicentre, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of BP1.4979 in adult patients with primary premature ejaculation

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Prospective randomized study on sexual health and self-perceived quality of life (PROMs) in patients treated for cervical cancer

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Human papillomavirus vaccine effectiveness study among men who have sex with men

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

ABCSG 45: A prospective, open, randomized, phase II study of carboplatin/olaparib in the pre-operative treatment of patients with triple-negative primary breast cancer which exhibit the features of positive homologous recombination deficiency (HRD) status

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase I/II safety and efficacy study of Vibrio alginolyticus collagenase in patients with Peyronie’s Disease A Phase I single ascending dose with a Phase II expansion, safety, tolerability, efficacy, pharmacokinetics and immunogenicity study

Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

PRODIGE 85 (FFCD 1804) – KANALRAD Prospective randomized phase III study evaluating induction chemotherapy (modified DCF 4 cycles) followed by chemoradiotherapy compared to standard chemoradiotherapy for locally advanced anal squamous cell carcinoma (T3-4 or N1a, b or c)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Sexual Health trials by city

Sexual Health in Toronto Sexual Health in Vancouver Sexual Health in Montreal Sexual Health in Calgary Sexual Health in Edmonton Sexual Health in Ottawa Sexual Health in Winnipeg Sexual Health in Quebec City Sexual Health in Hamilton Sexual Health in Kitchener Sexual Health in London Sexual Health in Halifax Sexual Health in New York Sexual Health in Los Angeles Sexual Health in Chicago Sexual Health in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease